Table 2.
Baseline characteristics of patients with and without gout
| Demographic data | Patients with Gout n = 7900 |
Patients without Gout n = 7900 |
P value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Age (years)a | 50 (40–64) | 50 (40–64) | |||
| ≥ 65 | 1791 | 11.5 | 1791 | 11.5 | .999 |
| < 65 | 6109 | 88.6 | 6109 | 88.6 | |
| Sex | |||||
| Male | 5409 | 83.9 | 5409 | 83.9 | .999 |
| Female | 2491 | 16.1 | 2491 | 16.1 | |
| Comorbidities | |||||
| Diabetes mellitus | 1664 | 9.6 | 950 | 4.5 | <.001* |
| Hypertension | 3240 | 24.3 | 1887 | 9.8 | <.001* |
| Dyslipidemia | 2230 | 14.0 | 1000 | 4.8 | <.001* |
| Cerebrovascular disease | 1147 | 6.9 | 829 | 3.7 | <.001* |
| Chronic lung disease | 989 | 4.9 | 684 | 1.9 | <.001* |
| Nephropathy | 1219 | 5.9 | 661 | 2.8 | <.001* |
| Chronic liver disease | 2713 | 19.4 | 1638 | 8.7 | <.001* |
| Autoimmune disease | 316 | 2.2 | 163 | 1.2 | <.001* |
| Degree of urbanization | <.001* | ||||
| Urban | 4186 | 56.9 | 4552 | 62.2 | |
| Suburban | 2853 | 35.2 | 2694 | 32.0 | |
| Rural | 861 | 7.9 | 654 | 5.8 | |
| Income group | .023* | ||||
| High income | 984 | 15.6 | 1007 | 17.0 | |
| Medium income | 1314 | 49.2 | 1261 | 50.4 | |
| Low income | 4184 | 19.9 | 4073 | 17.8 | |
| No income | 1418 | 15.4 | 1559 | 14.8 | |
| Follow-up yearsa | 13.36 (13.04–13.65) | 13.36 (13.04–13.63) | .005* | ||
a indicates Median (interquartile range); * indicates statistical significance